Gabitzsch; Elizabeth

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gabitzsch; Elizabeth.The latest application filed is for "combination immunotherapies comprising il-15 superagonists".

Company Profile

9.11.17

Gabitzsch; Elizabeth - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for combination immunotherapy Grant 11,352,642 - Jones , et al. June 7, 2	2022-06-07
Combination immunotherapies comprising IL-15 superagonists Grant 11,304,998 - Jones , et al. April 19, 2	2022-04-19
Methods and compositions for combination immunotherapy Grant 11,149,087 - Jones , et al. October 19, 2	2021-10-19
Compositions and methods for tumor vaccination and immunotherapy involving HER antigens Grant 11,116,827 - Jones , et al. September 14, 2	2021-09-14
Compositions and methods for alphavirus vaccination Grant 11,104,916 - Jones , et al. August 31, 2	2021-08-31
Combination Immunotherapies Comprising Il-15 Superagonists App 20210260175 - Jones; Frank R. ; et al.	2021-08-26
Combination immunotherapies comprising IL-15 superagonists Grant 11,020,467 - Jones , et al. June 1, 2	2021-06-01
Compositions and methods for flavivirus vaccination Grant 10,835,596 - Jones , et al. November 17, 2	2020-11-17
Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein Grant 10,695,417 - Jones , et al.	2020-06-30
Compositions And Methods For Flavivirus Vaccination App 20200171140 - JONES; Frank R. ; et al.	2020-06-04
Compositions And Methods For Alphavirus Vaccination App 20200172925 - JONES; Frank R. ; et al.	2020-06-04
Combination Immunotherapies Comprising Il-15 Superagonists App 20200155662 - JONES; Frank R. ; et al.	2020-05-21
Compositions And Methods For Tumor Vaccination And Immunotherapy Involving Her Antigens App 20200147193 - JONES; Frank R. ; et al.	2020-05-14
Replication defective adenovirus vector in vaccination Grant 10,563,224 - Jones , et al. Feb	2020-02-18
Compositions And Methods For The Treatment Of Human Papillomavirus (hpv)-associated Diseases App 20190134195 - JONES; Frank R. ; et al.	2019-05-09
Compositions And Methods For Tumor Vaccination And Immunotherapy Involving Her2/neu App 20190134174 - JONES; Frank R. ; et al.	2019-05-09
Compositions And Methods For Tumor Vaccination Using Prostate Cancer-associated Antigens App 20190125852 - JONES; Frank R. ; et al.	2019-05-02
Methods And Compositions For T-cell Immunotherapy App 20190030151 - Jones; Frank R. ; et al.	2019-01-31
Methods And Compositions For Influenza Vaccination App 20190022209 - Jones; Frank R. ; et al.	2019-01-24
Methods And Compositions For Combination Immunotherapy App 20180344832 - JONES; Frank R. ; et al.	2018-12-06
Methods And Compositions For Combination Immunotherapy App 20180187211 - Jones; Frank R. ; et al.	2018-07-05
Methods And Compositions For Ebola Virus Vaccination App 20170368161 - Jones; Frank R. ; et al.	2017-12-28
Replication Defective Adenovirus Vector In Vaccination App 20170165341 - Jones; Frank R. ; et al.	2017-06-15
Replication defective adenovirus vector in vaccination Grant 9,605,276 - Jones , et al. March 28, 2	2017-03-28
Replication Defective Adenovirus Vector In Vaccination App 20160076053 - Jones; Frank R. ; et al.	2016-03-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.